Skip to main content
HairCited

Treatment of female pattern hair loss with the androgen receptor antagonist flutamide.

Anosha Yazdabadi, Rod Sinclair
Case Report The Australasian journal of dermatology 2011 44 Zitierungen
PubMed DOI
<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'pmid\u003D21605098'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

Study Design

Studientyp
Case Reports
Population
None
Intervention
Treatment of female pattern hair loss with the androgen receptor antagonist flutamide. None
Vergleichsgruppe
None
Primärer Endpunkt
hair loss
Wirkungsrichtung
Mixed
Verzerrungsrisiko
High

Abstract

Female pattern hair loss is a common but difficult to manage condition. Commonly used treatments include oral antiandrogens such as spironolactone and topical minoxidil. The response to treatment is variable. We report a woman whose hair loss progressed while using spironolactone and topical minoxidil in combination, but reversed with flutamide, a potent androgen receptor antagonist.

Zusammenfassung

A woman whose hair loss progressed while using spironolactone and topical minoxidil in combination, but reversed with flutamide, a potent androgen receptor antagonist is reported.

Used In Evidence Reviews

Similar Papers